关于中科院成都信息技术股份有限公司 第四届董事会第六次会议相关事项的 独立意见 (2023 年 8 月 28 日) 根据《中华人民共和国公司法》《关于在上市公司建立独立董事 的指导意见》《深圳证券交易所创业板股票上市规则》以及《公司章 程》等有关法律法规和规范性文件的规定，我们作为中科院成都信息 技术股份有限公司（以下简称"公司"）的独立董事，对公司第四届 董事会第六次会议的相关事项进行了认真审核，发表如下独立意见： 一、对《关于 2023 年半年度募集资金存放与使用情况专项报告 的议案》的独立意见 经审核，我们认为，公司 2023 年半年度募集资金的存放和使用 情况符合中国证监会、深圳证券交易所关于上市公司募集资金存放和 使用的相关规定，公司对募集资金的管理遵循专户存放、规范使用、 及时披露、严格管理的原则，不存在变相改变募集资金投向、损害股 东利益及违反相关规定的情形。我们全体独立董事对《关于 2023 年 半年度募集资金存放与使用情况专项报告的议案》一致表示同意。 二、对《关于公司第三届高管人员任期业绩考核结果及奖惩情况 的议案》的独立意见 经审核，我们认为：公司第三届高管人员在任期内勤勉尽责，遵 纪守 ...

证券代码：300678 证券简称：中科信息 公告编号：2023-063 中科院成都信息技术股份有限公司 第四届监事会第四次会议决议公告 本公司及监事会全体成员保证信息披露的内容真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏。 一、监事会会议召开情况 中科院成都信息技术股份有限公司(以下简称"公司")第四届监事 会第四次会议于 2023 年 8 月 17 日以电子邮件方式发出会议通知，于 2023 年 8 月 28 日以通讯方式召开。会议应参与表决监事为 3 名，实际 参与表决监事 3 名，参与表决的监事人数符合法律和公司章程的规定。 会议由监事会主席帅红涛主持，董事会秘书列席了会议。 二、监事会会议审议情况 经与会监事审议并投票表决，通过了如下事项： （一）审议通过《关于 2023 年半年度报告及其摘要的议案》 表决结果：赞成 3 票；反对 0 票；弃权 0 票。 （二）审议通过《关于 2023 年半年度募集资金存放与使用情况专 项报告的议案》 具体内容详见公司于同日在巨潮资讯网(http://www.cninfo.com.cn) 披露的《关于 2023 年半年度募集资金存放与使用情况的专项报告》。 ...

中科院成都信息技术股份有限公司 2023 年半年度非经营性资金占用及其他关联资金往来情况汇总表 编制单位：中科院成都信息技术股份有限公司 单位：万元 | 非经营性资金占 | | 占用方与上 | 上市公司核算 | 2023 | 年期初占 | 2023 年度占 用累计发生 | 2023 年度占 | 2023 | 年度偿还 | 2023 | 年期末占 | 占用形 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | 资金占用方名称 | 市公司的关 | | | | | 用资金的利 | | | | | | 占用性质 | | 用 | | 联关系 | 的会计科目 | | 用资金余额 | 金额（不含 | 息（如有） | | 累计发生金额 | | 用资金余额 | 成原因 | | | | | | | | | 利息） | | | | | | | | | 控股股东、实际 | | | | | | | | | | | | | | | 控制人及其附属 | | | | | | | | | | | | | | ...

证券代码：300678 证券简称：中科信息 中科院成都信息技术股份有限公司 投资者活动记录表 编号：2023-07 | --- | --- | --- | |------------|---------------|------------| | | □特定对象调研 | 分析师会议 | | | □媒体采访 | 业绩说明会 | | 投资者关系 | | | | 活动类别 | □新闻发布会 | 路演活动 | | | 现场参观 | □电话会议 | □其他： （请文字说明其他活动内容） 瀚川投资：陶 冶 山西证券：吴 桐 宏利基金：徐雨楠 兴业证券：陈 鑫 参与单位名 长安基金：崔甲子 人保资产：李哲超 博思资产：刘尹博 红土创新：汪国瑞 称 榕湖投资：黄 卓 诺安基金：简 华 道禾咨询：陈达森 鹏华基金：张 官 长江资管：杨书权 国金证券：欧阳瑞 张 婕 江柯舟 及人员姓名 中邮证券：蒲尚坤 丁子惠 孙业良 张露予 时间 2023 年 7 月 18 日-2023 年 7 月 19 日 地点 公司7楼会议室 公司接待人 员 姓名 董事会秘书：刘小兵 Q1. 中科信息去年的订单与收入有明显的增长，但今年一季报中 投资者关 ...

证券代码：300678 证券简称：中科信息 中科院成都信息技术股份有限公司 投资者活动记录表 编号：2023-06 | --- | --- | --- | --- | --- | --- | |----------------|--------------------------|------------------|-------|------------------------------------------------|--------------------------------------| | | | | | | | | | | | | | | | | □特定对象调研 | | | 分析师会议 | | | 投资者关系活动 | □媒体采访 | | | 业绩说明会 | | | 类别 | □新闻发布会 | | | 路演活动 | | | | 现场参观 | | | □电话会议 | | | | □其他： | | | （请文字说明其他活动内容） | | | | 天府对冲基金学会 | | | 徐 涵、刘小华、唐金琼、温雨凡、姚方酥 | | | | 光大证券 | | | 汤中建、苟 彬；安信证券 程 密；百仑基 ...

证券代码：300678 证券简称：中科信息 中科院成都信息技术股份有限公司 投资者活动记录表 编号：2023-05 □特定对象调研 分析师会议 □媒体采访 业绩说明会 投资者关系活动 □新闻发布会 路演活动 类别 现场参观 □电话会议 □其他： （请文字说明其他活动内容） 东北证券：韩金呈 参与单位名称及 人员姓名 清河资本：李泽豪 时间 2023 年 5 月 12 日 地点 公司七楼会议室 方式 线下交流 上市公司接 待人员姓名 董事会秘书刘小兵，技术中心肖庆、陈科 一、 参观公司展厅，了解基本情况 投资者关系活动 二、 沟通交流 主要内容介绍 | --- | |----------------------------------------------------------------| | Q1.公司在高速机器视觉方面除了在印钞和烟草方面，未来会在哪些领 | | 域开展业务？可能会遇到哪些竞争对手？ | | A：目前，公司的高速机器视觉技术主要应用在印钞、烟草行业以及现 | | 场会议选举场景，近两年又拓展了新能源电池、汽车玻璃、电子玻璃、 | | 半导体等高端连续制造业的产品质量检测场景，这项技术的 ...

Financial Performance - The company's operating revenue for Q1 2023 was ¥74,535,937.15, representing a 9.01% increase compared to ¥68,374,192.97 in the same period last year[3]. - The net profit attributable to shareholders for Q1 2023 was ¥9,369,849.59, reflecting a 17.13% increase from ¥7,999,650.28 year-on-year[3]. - The basic earnings per share for Q1 2023 was ¥0.0474, an increase of 17.04% compared to ¥0.0405 in the same period last year[3]. - Total operating revenue for Q1 2023 was CNY 74,535,937.15, an increase of 9.5% compared to CNY 68,374,192.97 in the same period last year[20]. - Net profit for Q1 2023 was CNY 8,166,481.07, a decrease of 14.0% from CNY 9,504,245.43 in Q1 2022[21]. Cash Flow and Liquidity - The net cash flow from operating activities decreased by 88.23%, amounting to -¥123,663,827.04, primarily due to significant procurement payments related to project implementation[3][8]. - The net cash flow from operating activities for Q1 2023 was -CNY 123,663,827.04, worsening from -CNY 65,698,961.02 in the previous year[23]. - The net cash flow from investment activities was -8,041,955.28 CNY, compared to -59,157,633.29 CNY in the previous period[24]. - The total cash inflow from financing activities was 950,000.00 CNY, down from 162,057,682.29 CNY year-over-year[24]. - The net increase in cash and cash equivalents was -131,280,291.05 CNY, contrasting with an increase of 36,819,969.60 CNY in the previous period[24]. - The ending balance of cash and cash equivalents was 286,252,306.42 CNY, compared to 282,427,415.18 CNY at the end of the previous period[24]. Assets and Liabilities - Total assets at the end of Q1 2023 were ¥1,053,978,845.07, down 10.61% from ¥1,179,034,494.46 at the end of the previous year[4]. - The total liabilities as of Q1 2023 were CNY 208,212,618.27, a decrease from CNY 344,393,015.48 in the previous year[21]. - The company's total liabilities decreased to RMB 199,229,119.66, reflecting a slight reduction compared to the previous period[17]. - The total current liabilities decreased to RMB 199,229,119.66 from RMB 203,802,021.11, showing a reduction of about 2.8%[17]. Equity and Shareholder Information - The company's total equity attributable to shareholders increased by 1.48% to ¥847,278,145.21 from ¥834,950,028.88 at the end of the previous year[4]. - The total equity attributable to shareholders of the parent company was CNY 847,278,145.21, an increase from CNY 834,950,028.88 year-over-year[21]. - The company reported a total of 73,633,332 shares under lock-up agreements, with 60,318,434 shares held by the controlling shareholder, China Academy of Sciences Holdings Co., Ltd.[12]. - The company has committed to not transferring shares for 18 months following the issuance of new shares on December 10, 2021[13]. Expenses and Costs - Total operating costs for Q1 2023 were CNY 72,377,873.78, up from CNY 63,901,444.31, reflecting a year-over-year increase of 13.0%[20]. - Research and development expenses for Q1 2023 were CNY 5,739,796.03, down from CNY 6,772,538.26, indicating a reduction of 15.3%[21]. - Sales expenses increased to CNY 10,291,018.00 in Q1 2023, compared to CNY 8,636,274.72 in the same period last year, marking a rise of 19.1%[21]. Other Income and Taxation - Other income increased by 82.47% year-on-year, mainly due to an increase in government subsidies received[10]. - The company reported a 129.80% increase in non-operating income, primarily from penalties received for contract breaches[10]. - The company experienced a 135.17% increase in taxes and surcharges compared to the same period last year, mainly due to an increase in value-added tax surcharges[7]. Audit Status - The company’s first-quarter report was not audited[25].

Financial Performance - The company's operating revenue for Q1 2023 was ¥74,535,937.15, representing a 9.01% increase compared to ¥68,374,192.97 in the same period last year[3]. - The net profit attributable to shareholders was ¥9,369,849.59, reflecting a 17.13% increase from ¥7,999,650.28 year-on-year[3]. - The basic earnings per share increased by 17.04% to ¥0.0474 from ¥0.0405 in the same period last year[3]. - The profit attributable to the parent company for Q1 2023 was ¥9,369,849.59, an increase of 17.2% compared to ¥7,999,650.28 in Q1 2022[21]. - The total comprehensive income attributable to the parent company was CNY 9,369,849.59, an increase from CNY 7,999,650.28 in the previous period, representing a growth of approximately 17.2%[22]. Cash Flow - The net cash flow from operating activities decreased by 88.23%, amounting to -¥123,663,827.04, primarily due to significant procurement payments related to project implementation[3][8]. - Cash inflow from operating activities was CNY 99,592,588.01, compared to CNY 108,778,085.19 in the previous period, indicating a decrease of approximately 8.9%[22]. - Cash outflow from operating activities totaled CNY 223,256,415.05, up from CNY 174,477,046.21, marking an increase of about 28%[23]. - The net cash flow from operating activities was negative at CNY -123,663,827.04, worsening from CNY -65,698,961.02 in the previous period[22]. - Cash flow from investing activities was negative at CNY -8,041,955.28, compared to CNY -59,157,633.29 in the previous period, showing an improvement[23]. - Cash flow from financing activities generated a net inflow of CNY 425,491.27, a significant decrease from CNY 161,676,563.91 in the previous period[23]. Assets and Liabilities - The total assets at the end of the reporting period were ¥1,053,978,845.07, a 2.22% increase from ¥1,031,098,224.85 at the end of the previous year[4]. - The total assets of the company as of March 31, 2023, amounted to RMB 1,053,978,845.07, a decrease from RMB 1,179,034,494.46 at the beginning of the year[16]. - The company's cash and cash equivalents decreased to RMB 301,140,145.92 from RMB 432,349,836.77, reflecting a decline of approximately 30.3%[16]. - The total liabilities as of Q1 2023 were ¥208,212,618.27, a decrease from ¥344,393,015.48 in the previous period[18]. - The total current liabilities decreased to RMB 199,229,119.66 from RMB 203,802,021.11, a reduction of about 2.8%[17]. Inventory and Receivables - The company's inventory increased by 38.84% compared to the beginning of the period, mainly due to significant costs associated with unfinished project implementations[7]. - Accounts receivable increased to RMB 255,574,919.68 from RMB 216,147,148.77, representing a growth of about 18.2%[17]. - Inventory rose to RMB 165,019,557.86, up from RMB 118,853,196.43, indicating an increase of approximately 38.7%[17]. Shareholder Information - The company reported a total of 73,633,332 shares with restrictions on sale, with the largest shareholder being the Chinese Academy of Sciences Holding Co., Ltd. holding 60,318,434 shares[12]. - The company has committed to a lock-up period for its shares, with the largest shareholder's shares set to be released on June 10, 2023[12]. - The company plans to release part of the restricted shares after the 2023 annual report is disclosed, indicating a strategy for potential liquidity[12]. Expenses - Total operating costs for Q1 2023 were ¥72,377,873.78, up 13.2% from ¥63,901,444.31 in the same period last year[20]. - Research and development expenses for Q1 2023 were ¥5,739,796.03, down 15.3% from ¥6,772,538.26 in Q1 2022[21]. - Sales expenses increased to ¥10,291,018.00 in Q1 2023, compared to ¥8,636,274.72 in Q1 2022, reflecting a rise of 19.1%[21]. Other Financial Metrics - The company's other income grew by 82.47%, mainly due to an increase in government subsidies received[10]. - The company's credit impairment losses increased by 123.80%, attributed to better collection of receivables and reversals of bad debts[10]. - The weighted average return on equity was 1.12%, a slight decrease from 1.25% in the previous year[3]. - The company reported a financial income of ¥703,842.65 in Q1 2023, significantly up from ¥169,770.49 in Q1 2022[21]. - The company did not conduct any mergers or acquisitions during this reporting period[22]. Audit Status - The first quarter report was not audited[24].

证券代码：300678 证券简称：中科信息 答：尊敬的投资者，您好！公司积极投身数字中国建设，努力推进信息技术 创新在数字政府建设中的布局。公司作为中国数字会议一流品牌、党和国家 中科院成都信息技术股份有限公司 中科信息 2022 年度业绩说明会 投资者活动记录表 编号：2023-01 | | □特定对象调研 | □分析师会议 | | --- | --- | --- | | 投资者关系 活动类别 | □媒体采访 | 业绩说明会 | | | □新闻发布会 | 路演活动 | | | □现场参观 □电话会议 | | | | □其他： （请文字说明其他活动内容） | | | 参与单位名 | | | | 称 | 中科信息2022年度业绩说明会采用网络远程方式进行，面向全体投资者 | | | 及人员姓名 | | | | 时间 | 2023 年 4 月 18 日 15:00-17:00 | | | 地点 | 深圳证券交易所"互动易平台"http://irm.cninfo.com.cn"云访谈"栏目 | | | | 主持人：中科信息 | | | 公司接待人 | 董事长, 总经理：史志明 | | | 员 | 副总经理、财务 ...

Financial Performance - The company's operating revenue for 2022 was ¥554,711,552.61, representing an increase of 11.97% compared to ¥495,411,270.57 in 2021[20]. - The net profit attributable to shareholders for 2022 was ¥50,265,875.46, up 16.57% from ¥43,119,962.18 in 2021[20]. - The net profit after deducting non-recurring gains and losses was ¥36,434,444.76, a significant increase of 49.44% from ¥24,380,270.12 in 2021[20]. - The net cash flow from operating activities surged to ¥133,335,608.46, a remarkable increase of 376.94% compared to ¥27,956,228.50 in 2021[20]. - The total assets at the end of 2022 reached ¥1,179,034,494.46, marking a growth of 19.63% from ¥985,590,857.17 at the end of 2021[20]. - The net assets attributable to shareholders increased by 31.76% to ¥834,950,028.88 at the end of 2022, up from ¥633,686,514.89 in 2021[20]. - The basic earnings per share for 2022 was ¥0.2553, reflecting an increase of 11.83% from ¥0.2283 in 2021[20]. - The diluted earnings per share also stood at ¥0.2553, consistent with the basic earnings per share[20]. - The weighted average return on equity for 2022 was 6.27%, slightly down from 6.38% in 2021[20]. - The company achieved a total revenue of 55,471.16 million CNY in 2022, representing a year-on-year growth of 11.97%[136]. - The net profit attributable to shareholders was 5,026.59 million CNY, an increase of 16.57% compared to the previous year[136]. - The company signed new contracts worth 797 million CNY in 2022, which is a growth of 33.80% from 2021[136]. Risk Management - The company emphasizes the importance of risk awareness regarding forward-looking statements and future plans, urging investors to understand the differences between plans, forecasts, and commitments[4]. - The company has a comprehensive risk management section in its report, detailing potential operational risks and corresponding mitigation strategies[4]. Market Expansion and Strategy - The company has set a target to expand its market presence by entering three new regions by 2023, aiming for a 20% increase in market share[37]. - New product launches are expected to contribute an additional 300 million yuan in revenue in 2023, with a focus on AI-driven solutions[37]. - The company plans to establish partnerships with five key industry players to enhance its service capabilities and market reach by the end of 2023[37]. - A strategic acquisition of a smaller tech firm is expected to be finalized in Q2 2023, which will enhance the company's technological capabilities[37]. - The company aims to improve operational efficiency by 15% through the implementation of new technologies and process optimizations in 2023[37]. - The company is focusing on developing a comprehensive AI service platform, with an investment of 100 million yuan allocated for this initiative in 2023[37]. Industry Insights - The core AI industry market size in China exceeded 400 billion, with projections to surpass 450 billion by 2025[33]. - The AI industry is recognized as a strategic innovation area in China's 14th Five-Year Plan, receiving strong government support[33]. - The global AI enterprise count exceeded 23,000 as of July 2022, indicating significant growth in the AI sector[39]. - The software and information technology service industry is transitioning from a product-centric to a service-centric model, enhancing the integration of hardware, software, and services[51]. - The market for IT application software and specialized services is projected to grow significantly due to rising labor costs and the need for enhanced core competitiveness[52]. Research and Development - The company is investing 200 million yuan in R&D for new technologies, particularly in artificial intelligence and blockchain, to enhance product offerings[37]. - The company has increased its R&D investment, led by a team from the Chinese Academy of Sciences, to maintain its leading position in high-speed machine vision and intelligent analysis[94]. - The company added 3 invention patents, 30 utility model patents, and 28 design patents in 2022, showcasing its commitment to innovation and R&D[153]. - The company has a strong R&D foundation, having undertaken multiple national key research projects and received numerous awards, including nearly 100 provincial and national science and technology awards[152]. Digital Transformation - The company is actively pursuing forward-looking research in areas such as smart security, 5G communication, and blockchain technology[153]. - The company is focusing on digital transformation in the oil and gas sector, leveraging AI and big data technologies to drive innovation[142]. - The company is developing new products in smart healthcare, including AI-assisted anesthesia systems, with ongoing upgrades and certifications[171]. - The company is integrating AI and big data technologies to optimize image detection models, enhancing production efficiency and quality control[91]. Government and Policy Support - The software and information technology services sector is recognized as a pillar industry crucial for national economic and social development, receiving strong policy support[55]. - The government has initiated a national integrated government big data system, aiming to enhance data sharing and utilization for better governance[145]. Customer Engagement and Retention - The company has a customer retention rate of 34.95% for clients with over five years of cooperation, indicating strong customer loyalty[136]. - The company is actively pursuing market expansion through differentiated marketing strategies tailored to regional needs[87]. Financial Health and Investments - The company reported a net cash flow from investment activities of -¥60,998,524.10, a significant increase of 1,269.41% compared to the previous year, due to the purchase of financial products[192]. - The net cash flow from financing activities rose by 272.64% to ¥99,588,067.53, primarily due to fundraising from the issuance of new shares for subsidiary acquisitions[192]. - The company reported a significant increase in cash and cash equivalents, rising to 432,349,836, which is 36.67% of total assets, up from 26.38%[196].